U.S. stocks experienced a downturn, with significant losses noted toward the end of trading. The S&P 500 fell approximately 1.4%, echoing the performance of the Dow and the NASDAQ, which declined by 1.3% and 1.9% respectively.
These are the top stocks that gained the attention of retail traders and investors throughout the day:
Novavax, Inc. NVAX closed with an 8.18% increase at $7.67, marking an intraday high of $8.15 and a low of $6.73. The stock's 52-week range is between $5.61 and $25.66. The surge followed the FDA's Emergency Use Authorization for Novavax’s updated Covid-19 vaccine, Adjuvanted (2023-2024 Formula), for individuals aged 12 and older. This development comes on the heels of similar approvals for Moderna and the Pfizer-BioNTech vaccines.
Palantir Technologies Inc. PLTR experienced a 6.23% decline to close at $14.9, with an intraday high of $15.77 and low of $14.82. The stock's 52-week performance ranged from $5.92 to $20.24. Despite the decline, Jim Cramer acknowledged on CNBC's “Mad Money Lightning Round” that Palantir had a “really good quarter” and lived up to the hype, with the stock up over 148% in 2023.
Digital World Acquisition Corporation DWAC saw a 1.88% increase, closing at $15.72, and marking an intraday range of $15.3 to $15.95, with a 52-week range of $12.34 to $29.8. The stock's movement is intertwined with the ongoing civil fraud case against Donald Trump, with developments in the trial potentially influencing investor sentiment.
Tesla, Inc. TSLA closed at $245, a 2.62% decline, with an intraday high of $250.02 and low of $244.45. The 52-week range is $101.81 to $299.29. The decline is attributed to the introduction of a cheaper Model Y variant in the U.S., sparking concerns about potential impacts on the company's profit margins.
Photo by Phongphan on Shutterstock
Prepare for the day's trading with top premarket movers and news by Benzinga.
Engineered by Benzinga Neuro, Edited by Shivdeep Dhaliwal
The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.